Statistics for PTC Therapeutics (id:7403 PTCT)

Valuation metrics

Market cap

3.03B

Enterprise value

4.48B

Trailing P/E (ttm)

-5.16

Forward P/E

-10.66

PEG ratio

-10.66

Price/Sales (ttm)

3.36

Price/Book (mrq)

-3.15

Enterprise Value/Revenue

4.98

Enterprise Value/EBITDA

205.26

Overview

Shares outstanding

77.13M

Float

60.98M

Shares short

4.89M

% Held by insiders

0.02%

% Held by institutions

1.04%

Average volume (10 days)

770.54K

Average volume (90 days)

Price summary

52-Week low

20.74

52-Week high

46.98

52-Week change

50.31%

Beta

0.63

50-Day moving average

38.40

200-Day moving average

33.21

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-50.32%

Operating margin

-26.41%

Operational effectiveness

Return on assets

-5.15%

Return on equity

76.55%

Income statement

Revenue (ttm)

11.79

Revenue per share (ttm)

11.79

Quarterly revenue growth (yoy)

Gross profit (ttm)

872.34M

EBITDA

21.85M

Net income to common (ttm)

-453,200,992.00

Diluted EPS (ttm)

-5.94

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.02B

Total cash per share (mrq)

13.27

Total debt (mrq)

2.48B

Total Debt/Equity (mrq)

-2.35

Current ratio (mrq)

209.80%

Book value per share (mrq)

-13.70

Cash flow

Cash flow statement

-177,972,000.00

Levered free cash flow (LFCF)

-105,985,504.00